Hungarian phrama company Gedeon Richter Plc. has announced that it has submitted a Type II Variation application for RYEQO® to the European Medicines Agency (EMA) for the treatment of moderate to severe pain associated with endometriosis in adult women of reproductive age with a history of previous medical or surgical treatment for their endometriosis. RYEQO® […]